How Do Sleep Difficulties Interact With Anxiety, Depression and Health‐Related Quality of Life in Pulmonary Hypertension?
The Clinical Respiratory Journal · 2026
DOI: 10.1111/crj.70220 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Clinical Respiratory Journal, 2026. Verfasst von Jemma L Green und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Psychology, University of Sheffield, Sheffield, UK. Hauptthemen laut MEDLINE: Quality of Life, Hypertension, Pulmonary, Depression, Anxiety. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
Sleeping difficulties are prevalent among adults with pulmonary hypertension (PH), with most individuals studied to date reporting poor sleep. However, research investigating the impact of sleep on psychological distress and health‐related quality of life (HRQoL) in PH remains limited. This study aimed to identify the nature of common sleep difficulties in PH and the associated psychosocial impact using multiple self‐reported measures. A cross‐sectional survey was conducted with 111 adults with PH recruited from PH associations globally. Most identified as White (91%) and female (82%). Participants completed measures of overall sleep quality (Pittsburgh Sleep Quality Index), insomnia (Insomnia Severity Scale), daytime sleepiness (Epworth Sleepiness Scale), anxiety (Generalised Anxiety Disorder‐7), depression (Patient Health Questionnaire‐9) and HRQoL (emPHasis‐10). Regression analyses were used to inspect relationships between measures and other PH variables. A total of 79.8% of participants were identified as having poor sleep quality. The most prevalent sleep‐related difficulties were sleep disturbance and sleep latency issues. Insomnia and daytime sleepiness rates were also elevated (35% and 33.6%, respectively) and often co‐occurred. In addition, 40% and 29% of participants had clinical levels of depression and anxiety, respectively. All types of sleep difficulties were associated with lower HRQoL. A series of parallel mediation analyses suggested that this association was partially mediated by depressive symptoms. The findings indicate the need to routinely screen for both sleep difficulties and mood disturbance in this population. Further work is needed to understand whether existing brief sleep interventions are effective for use in PH, where multiple factors are influencing sleep quality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Psychology, University of Sheffield, Sheffield, UK.
- School of Psychology, University of Sussex, Brighton, UK.
- Division of Clinical Medicine, The University of Sheffield, Sheffield, UK.
- Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
- South Wales Clinical Psychology Training Programme, Cardiff and Vale University Health Board and Cardiff University, Cardiff, UK.
- Clinical and Applied Psychology Unit, University of Sheffield, Sheffield, UK.
ORCID-Profile: Jemma L Green, Vlad Costin, Iain Armstrong, Andrew R Thompson, Gregg H Rawlings
Zitieren
APA
Green, J. L., Costin, V., Armstrong, I., Thompson, A. R., & Rawlings, G. H. (2026). How Do Sleep Difficulties Interact With Anxiety, Depression and Health‐Related Quality of Life in Pulmonary Hypertension?. The Clinical Respiratory Journal. https://doi.org/10.1111/crj.70220
Vancouver
Green JL, Costin V, Armstrong I, Thompson AR, Rawlings GH. How Do Sleep Difficulties Interact With Anxiety, Depression and Health‐Related Quality of Life in Pulmonary Hypertension?. The Clinical Respiratory Journal. 2026. doi:10.1111/crj.70220
BibTeX
@article{Green2026,
author = {Green, Jemma L and Costin, Vlad and Armstrong, Iain and Thompson, Andrew R and Rawlings, Gregg H},
title = {How Do Sleep Difficulties Interact With Anxiety, Depression and Health‐Related Quality of Life in Pulmonary Hypertension?},
journal = {The Clinical Respiratory Journal},
year = {2026},
doi = {10.1111/crj.70220}
}
EUVIMED